SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006301
Filing Date
2021-05-06
Accepted
2021-05-06 17:28:31
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20210331x10q.htm   iXBRL 10-Q 1846641
2 EX-10.4 iova-20210331xex10d4.htm EX-10.4 100374
3 EX-31.1 iova-20210331xex31d1.htm EX-31.1 12232
4 EX-31.2 iova-20210331xex31d2.htm EX-31.2 12221
5 EX-32.1 iova-20210331xex32d1.htm EX-32.1 6997
6 EX-32.2 iova-20210331xex32d2.htm EX-32.2 7169
7 GRAPHIC iova-20210331x10q001.jpg GRAPHIC 80528
  Complete submission text file 0001558370-21-006301.txt   7911727

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20210331.xsd EX-101.SCH 50297
9 EX-101.CAL iova-20210331_cal.xml EX-101.CAL 50635
10 EX-101.DEF iova-20210331_def.xml EX-101.DEF 177956
11 EX-101.LAB iova-20210331_lab.xml EX-101.LAB 393687
12 EX-101.PRE iova-20210331_pre.xml EX-101.PRE 346140
13 EXTRACTED XBRL INSTANCE DOCUMENT iova-20210331x10q_htm.xml XML 1406020
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 21899112
SIC: 2836 Biological Products, (No Diagnostic Substances)